[Portal and superior mesenteric venous thrombosis secondary to oral contraceptive treatment. Two cases (author's transl)].
Two new cases of superior mesenteric, portal and pulmonary venous thrombosis enable the authors to stress the close link between this pathology and the ingestion of oral contraceptives. The resultant vessel wall changes and laboratory changes are described. Whilst complete normalisation at the end of treatment is confirmed, preventive treatment will soon be possible by virtue of the development of new natural substances already perfected in the United States and the Scandinavian countries and recently marketed in our own country.
D000328:Adult; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008641:Mesenteric Vascular Occlusion / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008642:Mesenteric Veins / Q000000981:diagnostic imaging; D009644:Norgestrel / Q000009:adverse effects*; D011169:Portal Vein / Q000000981:diagnostic imaging; D011655:Pulmonary Embolism / Q000139:chemically induced / Q000000981:diagnostic imaging; D011859:Radiography; D013927:Thrombosis / Q000139:chemically induced* / Q000000981:diagnostic imaging
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D009644:Norgestrel; D004997:Ethinyl Estradiol
Thromboses veineuses portale et mésentérique supérieure, secondaires a un traitement contraceptif oral. A propos de deux cas.